JPRN-UMIN000015631已完成2 期
A phase II study of preoperative TS-1+CDDP+DTX therapy for large type 3 or type 4 gastric cancer (OGSG 1402) - A phase II study of preoperative TS-1+CDDP+DTX therapy for large type 3 or type 4 gastric cancer (OGSG 1402)
Osaka Gastrointestinal cancer chemotherapy Study Group (OGSG)0 个研究点目标入组 48 人开始时间: 2014年11月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)with active double cancers excluding carcinoma in situ and/or prior cancer cured with longer than 5 year interval period 2)with a history of severe allergic reaction against medicines 3)with active infectious diseases (over 38 centigrade of body temperature) 4)pregnant or nursing female 5)male expecting pregnancy of partner 6)with a history of cardiac infarction within 6 months 7)under continuous steroids medication 8)under continuous medication of phenytoin or warfarin 9)with uncontrollable diarrhea (frequent movement and/or watery stool) 10)with HBs antigen positive or HCV antibody positive 11)With severe diseases (collagen disease, intestinal paralysis, interstitial pneumonitis, and/or ischemic cardiac disease) 12)Any other patients whom the physician in charge of the study judges to be unsuitable
研究者
相似试验
已完成
2 期
Phase II study of preoperative TS-1+CDDP therapy for advanced gastric cancer (OGSG 0004)Patients with unresectable gastric cancer due to limited inavasion or metastasis.JPRN-UMIN000000934OGSG30
已完成
1 期
Phase I/II trial of preoperative TS-1 + CDDP + radiation therapy for large type 3 or type 4 advanced gastric cancer (OGSG 1205)Resectable large type 3 or type 4 Gastric CancerJPRN-UMIN000008964Osaka Gastrointestinal cancer chemotherapy Study Group (OGSG)20
已完成
不适用
A phase I/II study of preoperative TS-1 combined chemoradiation therapy for patients with large type 3 or type 4 gastric cancer (OGSG 1303)gastric cancerJPRN-UMIN000013821Osaka Gastrointestinal cancer chemotherapy Study Group (OGSG)10
已完成
1 期
A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)JPRN-UMIN000002183OGSG40
招募中
不适用
PhaseI/II study of TS-1+CDDP in combination with Radiotherapy with unresectable and locally advanced for biliary tract cancerBiliary tract cancerJPRN-UMIN000007473Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University25